NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Down 54.0% in June

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a significant drop in short interest in the month of June. As of June 15th, there was short interest totaling 89,521 shares, a drop of 54.0% from the May 31st total of 194,483 shares. Approximately 1.3% of the shares of the stock are short sold. Based on an average daily volume of 2,421,281 shares, the short-interest ratio is presently 0.0 days.

NewGenIvf Group Price Performance

NIVF opened at $0.56 on Monday. The firm’s fifty day moving average is $1.11 and its two-hundred day moving average is $3.80. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. NewGenIvf Group has a twelve month low of $0.47 and a twelve month high of $372.00.

NewGenIvf Group (NASDAQ:NIVF) last released its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The company had revenue of $1.42 million for the quarter. Equities research analysts forecast that NewGenIvf Group will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a research note on Monday, April 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Insider Buying and Selling

In related news, major shareholder Financial Lp Hrt acquired 137,541 shares of the firm’s stock in a transaction on Friday, May 22nd. The shares were bought at an average cost of $0.99 per share, with a total value of $136,165.59. Following the completion of the acquisition, the insider owned 111,885 shares of the company’s stock, valued at $110,766.15. This trade represents a -536.10% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. 31.80% of the stock is currently owned by corporate insiders.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.